Assembly Biosciences INC (ASMB) Shareholder Capital Impact Advisors LLC Trimmed Its Position
Capital Impact Advisors Llc decreased its stake in Assembly Biosciences Inc (ASMB) by 82% based on its latest 2019Q2 regulatory filing with the SEC. Capital Impact Advisors Llc sold 56,475 shares as the company’s stock declined 18.51% . The institutional investor held 12,400 shares of the health care company at the end of 2019Q2, valued at $1.65M, down from 68,875 at the end of the previous reported quarter. Capital Impact Advisors Llc who had been investing in Assembly Biosciences Inc for a number of months, seems to be less bullish one the $423.26 million market cap company. The stock decreased 0.91% or $0.15 during the last trading session, reaching $16.25. About 287,999 shares traded. Assembly Biosciences, Inc. (NASDAQ:ASMB) has declined 69.75% since December 4, 2018 and is downtrend ...